¬ã¬ä¬à¬Ý ¬Ý¬Ñ¬Ò¬à¬â¬Ñ¬ä¬à¬â¬ß¬í¬Û ¬à¬ä¬Ü¬â¬í¬ä¬í¬Û | ||||||||||
SdvillEvato | 2022-08-14 | 182 | ||||||||
¬Ý¬Ñ¬Ò¬à¬â¬Ñ¬ä¬à¬â¬ß¬í¬Ö ¬á¬â¬Ö¬è¬Ú¬Ù¬Ú¬à¬ß¬ß¬í¬Ö ¬Ó¬Ö¬ã¬í ¬Ó¬Þ 510¬Õ Tegs: ¬Ý¬Ñ¬Ò¬à¬â¬Ñ¬ä¬à¬â¬ß¬í¬Ö ¬á¬â¬à¬Ò¬Ú¬â¬Ü¬Ú ¬Ü¬å¬á¬Ú¬ä¬î https://chimmed.ru/products/biochemistry?group=¬²¡°¬²¬²¬²¬²¬²¬×¬²¬²¡Æ&other-group=¬²¬²¬²¡Æ¬³¬³¬²¬×¬²+¬²¬²¬³+¬²¬²¬²¬²¬²¬³¬²¬³¬³¬²¬²¬²¢à+¬²¡¾¬²¬×¬²¬²¬²¬²¬²¬×¬²¬×&other-group=¬²¬³¬²¬²¡¾¬²¬×¬³¬²¬²¬× ¬ã¬ä¬à¬Ý ¬Ý¬Ñ¬Ò¬à¬â¬Ñ¬ä¬à¬â¬ß¬í¬Û ¬à¬Ü¬à¬æ 2019 ¬ã¬ä¬à¬Ý ¬Ý¬Ñ¬Ò¬à¬â¬Ñ¬ä¬à¬â¬ß¬í¬Û ¬à¬ã¬ä¬â¬à¬Ó¬ß¬à¬Û ¬ã¬Ý 14 2 ¬ã¬ä¬à¬Ý ¬Ý¬Ñ¬Ò¬à¬â¬Ñ¬ä¬à¬â¬ß¬í¬Û ¬à¬ã¬ä¬â¬à¬Ó¬ß¬à¬Û ¬ã ¬ß¬Ñ¬Õ¬ã¬ä¬â¬à¬Û¬Ü¬à¬Û |
18586 | endostatin murine, recombinant ¬Ü¬å¬á¬Ú¬ä¬î ¬à¬ß¬Ý¬Ñ... | LavillEvat | 2024-04-03 | 5 | |
18585 | anti-histone deacetylase 1 (hdac1) anti& ¬Ü¬å¬á¬Ú¬ä... | LavillEvat | 2024-03-31 | 6 | |
18584 | First revalidation, dilatation ptosis accountability... | axojaqeera | 2024-01-05 | 33 | |
18583 | L, documentation rotational, expressed accountabilit... | axojaqeera | 2024-01-05 | 33 | |
18582 | ¬Ü¬à¬Ý¬à¬ß¬Ü¬Ñ ¬Õ¬Ý¬ñ ¬Ó¬ï¬Ø¬ç caprisil c18 5 ¬Þ¬Ü¬Þ... | LavillEvat | 2023-10-28 | 67 | |
18581 | pyrex(r) vista(tm) volumetric pipette, & ¬Ü¬å¬á¬Ú¬ä... | LavillEvat | 2023-10-18 | 61 | |
18580 | 5-chloro-2-[(4-fluorobenzyl)oxy]benzoyl chloride †... | LavillEvat | 2023-10-13 | 67 | |
18579 | human gabrr1 gene orf cdna clone expression plasmid ... | LavillEvat | 2023-10-07 | 71 | |
18578 | Consider rehabilitating total symptom memory, append... | eshuhia | 2023-09-22 | 77 | |
18577 | Consider case-control crescent higher, health-relate... | eshuhia | 2023-09-22 | 71 | |
1 2 3 4 5 6 7 8 9 10 |